These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 676755)

  • 1. An allenic oxotremorine analogue.
    Claesson A; Asell A; Björkman S; Olsson LI
    Acta Pharm Suec; 1978; 15(2):105-10. PubMed ID: 676755
    [No Abstract]   [Full Text] [Related]  

  • 2. Acetylene compounds of potential pharmacological value. XXV. N-(4-pyrrolidino-2-butynyl)-N-alkylcarboxamides.
    Svensson U; Hacksell U; Dahlbom R
    Acta Pharm Suec; 1978; 15(1):67-70. PubMed ID: 645369
    [No Abstract]   [Full Text] [Related]  

  • 3. Acetylene compounds of potential pharmacological value. XXVII. Stereoselectivity of oxotremorine antagonists containing a chiral pyrrolidine group.
    Ringdahl B; Dahlbom R
    Acta Pharm Suec; 1978; 15(4):255-63. PubMed ID: 726907
    [No Abstract]   [Full Text] [Related]  

  • 4. Acetylene compounds of potential pharmacological value. XXIX. Stereoselectivity of N-(1-alkyl-4-pyrrolidino-2-butynyl)-substituted 2-pyrrolidones and succinimides as oxotremorine antagonists.
    Ringdahl B; Dahlbom R
    Acta Pharm Suec; 1979; 16(1):13-20. PubMed ID: 452907
    [No Abstract]   [Full Text] [Related]  

  • 5. Stereoselectivity of oxotremorine antagonists containing a chiral pyrrolidine group.
    Ringdahl B; Dahlbom R
    Experientia; 1978 Oct; 34(10):1334-5. PubMed ID: 738410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylene compounds of potential pharmacological value. XXVIII. Oxotremorine analogues substituted with a methyl group in the lactam ring.
    Ringdahl B; Muhi-Eldeen Z; Ljunggren C; Karlén B; Resul B; Dahlbom R
    Acta Pharm Suec; 1979; 16(2):89-94. PubMed ID: 474169
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis and pharmacological properties of N-[4-(1-azetidinyl)-2-butynyl]-2-pyrrolidone, a highly potent oxotremorine-like agent.
    Resul B; Lewander T; Zetterström T; Ringdahl B; Muhi-Eldeen Z; Dahlbom R
    J Pharm Pharmacol; 1980 Jun; 32(6):439-40. PubMed ID: 6106684
    [No Abstract]   [Full Text] [Related]  

  • 8. Stereoselectivity of some oxotremorine antagonists containing two chiral centres.
    Ringdahl B; Resul B; Dahlbom R
    J Pharm Pharmacol; 1979 Dec; 31(12):837-9. PubMed ID: 43369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional differences in receptor reserve for analogs of oxotremorine in vivo: implications for development of selective muscarinic agonists.
    Ringdahl B; Roch M; Jenden DJ
    J Pharmacol Exp Ther; 1987 Aug; 242(2):464-71. PubMed ID: 3612545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetylene compounds of potential pharmacological value. XXXVI. N-(4-tert-Amino-2-butynyl)-substituted 2(3H)-thiazolones and 2(3H)-oxazolones.
    Moses P; Dahlbom R
    Acta Pharm Suec; 1978; 15(3):175-80. PubMed ID: 716951
    [No Abstract]   [Full Text] [Related]  

  • 11. Heterogeneity of release-inhibiting muscarinic autoreceptors in heart atria and urinary bladder: a study with M(2)- and M(4)-receptor-deficient mice.
    Zhou H; Meyer A; Starke K; Gomeza J; Wess J; Trendelenburg AU
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):112-22. PubMed ID: 11819029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel oxotremorine-related heterocyclic derivatives: Synthesis and in vitro pharmacology at the muscarinic receptor subtypes.
    Dallanoce C; De Amici M; Barocelli E; Bertoni S; Roth BL; Ernsberger P; De Micheli C
    Bioorg Med Chem; 2007 Dec; 15(24):7626-37. PubMed ID: 17889543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and action of oxotremorine-related hybrid-type allosteric modulators of muscarinic acetylcholine receptors.
    Disingrini T; Muth M; Dallanoce C; Barocelli E; Bertoni S; Kellershohn K; Mohr K; De Amici M; Holzgrabe U
    J Med Chem; 2006 Jan; 49(1):366-72. PubMed ID: 16392821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of AIT-082, a purine derivative, on tremor induced by arecoline or oxotremorine in mice.
    Nannan G; Runmei Y; Fusheng L; Shoulan Z; Guangqing L
    Pharmacology; 2007; 80(1):21-6. PubMed ID: 17496436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxotremorine-induced cholinergic syndrome: modifications by levodopa and/or oral cytidine diphosphocholine.
    Saligaut C; Daoust M; Chadelaud M; Moore N; Chretien P; Boismare F
    Methods Find Exp Clin Pharmacol; 1985 Jan; 7(1):5-8. PubMed ID: 3990445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of beta-adrenergic blocking agents, with differing ancillary properties on oxotremorine induced tremor in mice.
    Alkondon M; Ray A; Sen P
    Indian J Exp Biol; 1984 Jul; 22(7):382-3. PubMed ID: 6150896
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclopropane analogues to acetylenic oxotremorine antagonists.
    Grundström K; Dahlbom R
    Acta Pharm Suec; 1972 Nov; 9(5):491-8. PubMed ID: 4650125
    [No Abstract]   [Full Text] [Related]  

  • 18. Acetylene compounds of potential pharmacological value. XXII. Base strength and biological activity in oxotremorine antagonists.
    Svensson U; Ringdahl B; Dahlbom R
    Acta Pharm Suec; 1975; 12(5-6):393-400. PubMed ID: 1217491
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of reserpine and tetrabenazine on the analgesic and rotarod activity of tremorine and oxotremorine in the mouse.
    Bite A; György L
    Acta Physiol Acad Sci Hung; 1972; 42(2):177-83. PubMed ID: 4667346
    [No Abstract]   [Full Text] [Related]  

  • 20. Muscarinic actions of an N-methyl-N-2-bromoethylamino analog of oxotremorine (BR 401) in the mouse.
    Ringdahl B; Jenden DJ
    J Pharmacol Exp Ther; 1987 Feb; 240(2):370-5. PubMed ID: 3806401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.